Equities

Bioretec Oy

Bioretec Oy

Actions
Health CareMedical Equipment and Services
  • Price (EUR)1.86
  • Today's Change0.04 / 2.20%
  • Shares traded92.63k
  • 1 Year change-18.06%
  • Beta--
Data delayed at least 15 minutes, as of Nov 22 2024 17:00 GMT.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Key statistics

On Friday, Bioretec Oy (BRETEC:HEX) closed at 1.86, 8.77% above its 52-week low of 1.71, set on Nov 19, 2024.
52-week range
Today
1.71Nov 19 20243.01Aug 15 2024
Open1.88
High1.93
Low1.83
Bid1.85
Offer1.86
Previous close1.82
Average volume37.55k
Shares outstanding20.34m
Free float14.08m
P/E (TTM)--
Market cap37.01m EUR
EPS (TTM)-0.1752
EUR
Data delayed at least 15 minutes, as of Nov 22 2024 17:00 GMT.
More ▼

Events & Activity

  • BRETEC:HEX trading volume exceeds daily average by +104.78%
  • BRETEC:HEX price reached a new 52-week low of 1.72 at 03:27 GMT
  • BRETEC:HEX price moved over +1.52% to 2.00
  • BRETEC:HEX price rises above 15-day moving average to 1.95 at 03:09 GMT
  • BRETEC:HEX price falls below 15-day moving average to 1.92 at 03:27 GMT
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.
S&P Global Market Intelligence Short Selling Activity © S&P Global Market Intelligence. All rights reserved.
Although S&P Global Market Intelligence has made every effort to ensure this data is correct, nevertheless no guarantee is given to the accuracy or completeness. Any opinions or estimates expressed herein are those of S&P Global Market Intelligence on the date of preparation and are subject to change without notice; however no such opinions or estimates constitute legal, investment or other advice. You must therefore seek independent legal, investment or other appropriate advice from a suitably qualified and/or authorised and regulated advisor prior to making any legal, investment or other decision. This is intended for information purposes only and is not intended as an offer or recommendation to buy, sell or otherwise deal in securities.